These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27895190)

  • 21. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
    Okuno K; Torimoto K; Cicalese SM; Preston K; Rizzo V; Hashimoto T; Coffman TM; Sparks MA; Eguchi S
    Hypertension; 2023 Mar; 80(3):668-677. PubMed ID: 36628961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial Mineralocorticoid Receptor Mediates Parenchymal Arteriole and Posterior Cerebral Artery Remodeling During Angiotensin II-Induced Hypertension.
    Diaz-Otero JM; Fisher C; Downs K; Moss ME; Jaffe IZ; Jackson WF; Dorrance AM
    Hypertension; 2017 Dec; 70(6):1113-1121. PubMed ID: 28974571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
    Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.
    Calderon LE; Liu S; Su W; Xie Z; Guo Z; Eberhard W; Gong MC
    PLoS One; 2012; 7(2):e31850. PubMed ID: 22363752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice.
    Gao P; Xu TT; Lu J; Li L; Xu J; Hao DL; Chen HZ; Liu DP
    J Mol Med (Berl); 2014 Apr; 92(4):347-57. PubMed ID: 24352856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats.
    Khuman MW; Harikumar SK; Sadam A; Kesavan M; Susanth VS; Parida S; Singh KP; Sarkar SN
    Toxicology; 2016 Dec; 374():29-41. PubMed ID: 27889505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells.
    Das S; Senapati P; Chen Z; Reddy MA; Ganguly R; Lanting L; Mandi V; Bansal A; Leung A; Zhang S; Jia Y; Wu X; Schones DE; Natarajan R
    Nat Commun; 2017 Nov; 8(1):1467. PubMed ID: 29133788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.
    Das S; Zhang E; Senapati P; Amaram V; Reddy MA; Stapleton K; Leung A; Lanting L; Wang M; Chen Z; Kato M; Oh HJ; Guo Q; Zhang X; Zhang B; Zhang H; Zhao Q; Wang W; Wu Y; Natarajan R
    Circ Res; 2018 Dec; 123(12):1298-1312. PubMed ID: 30566058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular Smooth Muscle-Specific EP4 Receptor Deletion in Mice Exacerbates Angiotensin II-Induced Renal Injury.
    Thibodeau JF; Holterman CE; He Y; Carter A; Cron GO; Boisvert NC; Abd-Elrahman KS; Hsu KJ; Ferguson SS; Kennedy CR
    Antioxid Redox Signal; 2016 Oct; 25(12):642-656. PubMed ID: 27245461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drebrin regulates angiotensin II-induced aortic remodelling.
    Zhang L; Wu JH; Huang TQ; Nepliouev I; Brian L; Zhang Z; Wertman V; Rudemiller NP; McMahon TJ; Shenoy SK; Miller FJ; Crowley SD; Freedman NJ; Stiber JA
    Cardiovasc Res; 2018 Nov; 114(13):1806-1815. PubMed ID: 29931051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide.
    Chinnakkannu P; Reese C; Gaspar JA; Panneerselvam S; Pleasant-Jenkins D; Mukherjee R; Baicu C; Tourkina E; Hoffman S; Kuppuswamy D
    PLoS One; 2018; 13(12):e0207844. PubMed ID: 30576317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.
    Sparks MA; Parsons KK; Stegbauer J; Gurley SB; Vivekanandan-Giri A; Fortner CN; Snouwaert J; Raasch EW; Griffiths RC; Haystead TA; Le TH; Pennathur S; Koller B; Coffman TM
    Hypertension; 2011 Mar; 57(3):577-85. PubMed ID: 21242463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-intensity pulsed ultrasound ameliorates angiotensin II-induced cardiac fibrosis by alleviating inflammation via a caveolin-1-dependent pathway.
    Zhao K; Zhang J; Xu T; Yang C; Weng L; Wu T; Wu X; Miao J; Guo X; Tu J; Zhang D; Zhou B; Sun W; Kong X
    J Zhejiang Univ Sci B; 2021 Oct; 22(10):818-838. PubMed ID: 34636186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.
    Antoniak S; Cardenas JC; Buczek LJ; Church FC; Mackman N; Pawlinski R
    Cardiology; 2017; 136(4):258-268. PubMed ID: 27880950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoplasmic Reticulum Chemical Chaperone 3-Hydroxy-2-Naphthoic Acid Reduces Angiotensin II-Induced Vascular Remodeling and Hypertension In Vivo and Protein Synthesis In Vitro.
    Cicalese S; Torimoto K; Okuno K; Elliott KJ; Rizzo V; Hashimoto T; Eguchi S
    J Am Heart Assoc; 2022 Dec; 11(23):e028201. PubMed ID: 36444851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure.
    Czikora I; Feher A; Lucas R; Fulton DJ; Bagi Z
    Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H376-85. PubMed ID: 25527780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.